SlideShare une entreprise Scribd logo
1  sur  38
Télécharger pour lire hors ligne
CNS STIMULANTS
1
Dr Laith M Abbas Al-Huseini
M.B.Ch.B, M.Sc., M.Res., Ph.D.
1. Psychomotor stimulants
cause: Excitement, Euphoria, Decrease feeling of
fatigue and Increase motor activity
Ex. Methylxanthines (caffeine, theobromine, theophylline),
nicotine, cocaine, amphetamine, atomoxetine, modafinil,
methylphenidate.
2. Hallucinogens (psychotomimetic)
Affect thought, perception, and mood
Ex. Lysergic acid diethylamide (LSD), Phencyclidine (PCP),
Tetrahydrocannabinol (THC), Rimonabant.
2
CNS stimulants
Therapeutic Indications and
Contraindications for CNS Stimulants
Obesity (anorectic agents).
Attention Deficit Hyperactivity Disorder (ADHD); lack
the ability to be involved in any one activity for longer
than a few minutes.
Narcolepsy: It is a relatively rare sleep disorder, that is
characterized by uncontrollable bouts of sleepiness
during the day. It is sometimes accompanied by
catalepsy, a loss in muscle control, or even paralysis
brought on by strong emotion, such as laughter.
Contraindications:
patients with anorexia, insomnia, asthenia, psychopathic
personality, a history of homicidal or suicidal tendencies.
3
1. Psychomotor stimulants
A. Methylxanthines
1. Theophylline (found in tea): long-acting,
prescribed for night-time asthma
2. Theobromine: found in cocoa.
3. Caffeine: (short-acting) the most widely
consumed
 found in coffee (200 mg/cup),
 carbonated soft drinks (60 mg/can),
 cocoa and chocolate
4
Mechanism of action: include
several mechanism have been proposed
Mechanism of action of methylxanthine
1-It inhibits phosphodiesterase enz. → ↑ cAMP
2- Adenosine (A1, A2 and A3) receptors antagonist
almost equally, which explains many of its cardiac effects
A2 receptors antagonist responsible for CNS stimulation
& smooth muscles relaxation
↓calcium in
Smooth muscles
↑ calcium in
CNS & heart
5
Actions
a. CNS:
 decrease in fatigue, increased alertness: 100-200 mg caffeine in 1 or 2
cups of coffees
 Anxiety & tremors- 1.5 g of caffeine: 12-15 cups of coffee
 Spinal cord stimulation: 2-5 g (very high dose)
Tolerance can rapidly develop
Withdrawal symptoms: feeling of fatigue & sedation.
b. CVS: at high dose of caffeine +ve inotropic and chronotropic
effects on the heart, ↑COP
c. Diuretic action: mild ↑ urinary output of Na+, Cl- and K+
d. Gastric mucosa: all methylxanthines stimulate secretion of HCl
e. Respiratory smooth muscle: bronchodilator, Rx asthma
replaced by β-agonists, corticosteroids.
6
Pharmacokinetics
 The methylxanthines are well absorbed orally.
 Caffeine distributes throughout the body, including
the brain. The drugs cross the placenta to the fetus
and is secreted into the mother's milk.
 All are metabolized in the liver, generally by the
CYP1A2 pathway, the metabolites are then excreted
in the urine.
Adverse effects
 Moderate doses: insomnia, anxiety, agitation
 High doses: emesis, convulsion
 Lethal dose (10 gm of caffeine): cardiac arrhythmia
 Suddenly stop: lethargy, irritability, headache
7
B. Nicotine:
 Nicotine is the active ingredient in tobacco.
 Used in smoking cessation therapy,
 Nicotine remains important, because:
 it is 2nd only to caffeine as the most widely used CNS
stimulant
 and 2nd only to alcohol as the most abused drug.
Actions of Nicotine:
Low dose: ganglionic depolarization
High dose: ganglionic blockade
8
Actions of Nicotine
I. CNS:
1. Low dose: euphoria, arousal, relaxation, improves
attention, learning, problem solving and reaction time.
2. High dose: CNS paralysis, severe hypotension
(medullary paralysis)
II. Peripheral effects:
 Stimulation of sympathetic ganglia and adrenal
medulla→↑ BP and HR (harmful in HTN patients)
 Stimulation of parasympathetic ganglia→↑ motor
activity of the bowel
 At higher doses, BP falls & activating ceases in both
GIT and bladder
9
Pharmacokinetics:
 highly lipid soluble absorbed everywhere (oral
mucosa, lung, GIT, skin).
 Crosses the placental membrane, secreted with milk.
 Most cigarettes contain 6-8 mg of nicotine, by
inhaling tobacco smoke, the average smoker takes in
1 to 2 mg of nicotine per cigarette.
 the acute lethal dose is 60 mg,
 90% of nicotine inhaled in smoke is absorbed.
 Tolerance to toxic effects of nicotine develops rapidly.
10
Adverse effects:
 CNS; irritability and tremors
 Intestinal cramps, diarrhea
 ↑HR & BP
Withdrawal syndrome:
nicotine is addictive substance
 physical dependence on nicotine
develops rapidly and can be
severe.
 Bupropion: can reduce the
craving for cigarettes
 Transdermal patch and chewing
gum containing nicotine
11
C. Varenicline
 Partial agonist at Nicotinic receptor in CNS.
 It produces less euphoric effects than those
produced by nicotine itself (nicotine is full agonist at
these receptors).
 Thus, it is useful as an adjunct in the management of
smoking cessation in patients with nicotine
withdrawal symptom.
 SE: Nausea, change in taste, vomiting, abdominal
pain, flatulence, and constipation.
 Serious side-effects, including suicidal behavior and
depression
12
D. Cocaine (highly addictive drug)
Mechanism of action:
blockade of reuptake of the
monoamines (NE, serotonin
and dopamine).
Thus, potentiates and
prolongs the CNS and
peripheral actions of these
monoamines.
Only clinical use as local
anesthetics.
13
Action:
 Initially produces the intense
euphoria by prolongation of
dopaminergic effects in the
brain’s pleasure system (limbic
system) producing the “Rush”.
 This follows by dysphoria in few
minutes as it is degraded by
plasma estrases
14
 Chronic intake of cocaine depletes dopamine.
This depletion triggers the vicious cycle of craving for
cocaine.
Pharmacological effects:
a. CNS-behavioral effects result from powerful
stimulation of cortex and brain stem.
 Cocaine acutely increases mental awareness and
produces a feeling of wellbeing and euphoria similar to
that produced by amphetamine.
 Like amphetamine, cocaine can produce hallucinations
and delusions of paranoia or grandiosity.
 Cocaine increases motor activity, and at high doses, it
causes tremors and convulsions, followed by
respiratory and vasomotor depression.
15
b. Sympathetic NS: peripherally potentiate the action
of NE→ fight or flight
c. Hyperthermia:
 impair sweating & cutaneous vasodilation
 ↓Perception of thermal discomfort
d. local anesthetic action: blockade of voltage-
activated Na+ channel.
 Cocaine is the only LA that causes vasoconstriction,
chronic inhalation of cocaine powder → necrosis and
perforation of the nasal septum
 Cocaine is often self-administered by chewing,
intranasal snorting, smoking, or intravenous (IV)
injection.
Pharmacological effects :
16
Adverse effects:
 Anxiety reaction that includes: hypertension,
tachycardia, sweating, and paranoia.
Because of the irritability, many users take cocaine with alcohol.
A product of cocaine metabolites and ethanol is cocaethylene,
which is also psychoactive and cause cardiotoxicity.
 Depression: Like all stimulant drugs, cocaine stimulation of the
CNS is followed by a period of mental depression.
 Addicts withdrawing from cocaine exhibit physical and
emotional depression as well as agitation.
The latter symptom can be treated with benzodiazepines or
phenothiazines.
 Toxic effects:
 Seizures treated by I.V diazepam
 Fatal cardiac arrhythmias treated by propranolol 17
E. Amphetamine
 Is a non catecholamine, (shows neurologic and clinical
effects quite similar to those of cocaine).
 dextroamphetamine is the major member of this class
compounds.
 methamphetamine (speed) is a derivative of
amphetamine that can be smoked and it is preferred
by many abusers.
 Methylenedioxymethamphetamine (also known as
MDMA, or Ecstasy) is a synthetic derivative of
methamphetamine with both stimulant and
hallucinogenic properties. 18
Mechanism of action:
Amphetamine, act by
 releasing intracellular
stores of catecholamines.
 also inhibits MAO, high
level catecholamines are
readily released into
synaptic spaces.
19
Actions:
a. CNS: the major behavioral effects of amphetamine
result from a combination of its dopamine and NE
release enhancing properties.
 Amphetamine stimulates the entire cerebrospinal
axis, brainstem, and medulla.
 This leads to increase alertness, decrease fatigue,
depressed appetite, and insomnia.
b. Sympathetic Nervous System: indirectly stimulating
the receptors through NE release.
20
Adverse effects:
The amphetamines may cause addiction, dependence,
tolerance, and drug seeking behavior.
a. CNS: insomnia, irritability, weakness, dizziness, tremor,
hyperactive reflex, confusion, delirium, panic states, and
suicidal tendencies, especially in mentally ill patients.
-Chronic amphetamine use produces a state of “amphetamine
psychosis” that resembles the psychotic episodes associated
with schizophrenia.
-Whereas long-term amphetamine is associated with psychic
and physical dependence, tolerance to its effects may occur
within few weeks.
21
Adverse effects:
The anorectic effect of amphetamine is due to its action
in the lateral hypothalamic feeding center.
b. CVS: palpitations, cardiac arrhythmia, HTN, anginal
pain, and circulatory collapse. Headache, chills, and
excess sweating may also occur.
c. GIT: anorexia, nausea, vomiting, abdominal cramps,
and diarrhea.
Overdoses are treated with chlorpromazine or
haloperidol, with urine acidification to enhance
excretion.
Contraindications: HTN, CV diseases, glaucoma,
hyperthyroidism, patients with a history of drug abuse
22
F. Atomoxetine
 It is a NE reuptake inhibitor (should not be taken by
individual on MAO inhibitors).
 Approved for ADHD (significant problems
of attention, hyperactivity, or acting impulsively) in
children and adults.
 SE: Nausea, Xerostomia (dry mouth), appetite loss,
Insomnia, Irritability, hypertension and Hostility.
 It is not habit forming and is not a controlled
substance.
23
G. Methylphenidate
 It has CNS stimulant properties similar to those of
amphetamine and may also lead to abuse.
 Methylphenidate is a more potent dopamine transport
inhibitor than cocaine, thus making more dopamine
available.
 It has less potential for abuse than cocaine, because it
enters the brain much more slowly than cocaine and,
does not increase dopamine levels as rapidly.
24
Therapeutic uses:
 Methylphenidate and its active isomer,
(Dexmethylphenidate), have been used for several
decades in the treatment of ADHD in children aged 6
to 16.
 It is also effective in the treatment of narcolepsy.
25
Adverse reactions:
 GIT effects are the most common; abdominal pain
and nausea.
 Other reactions include anorexia, insomnia,
nervousness, and fever.
 In seizure patients, methylphenidate seems to
increase the seizure frequency, especially if the
patient is taking antidepressants.
 Methylphenidate is contraindicated in patients with
glaucoma.
26
Narcolepsy: (day time sleepiness)
 Amphetamine, methylphenidate.
 Recently, a new drug, modafinil (wakefulness-
promoting agent) and its R-enantiomer derivative,
armodafinil, have become available to treat
narcolepsy.
 Modafinil produces fewer psychoactive and
euphoric effects as well as, alterations in mood,
perception, thinking, and feelings typical of other
CNS stimulants.
27
28
H. Picrotoxin (cocculin)
 Is a poisonous crystalline plant compound.
 It acts as a non-competitive channel blocker for
the GABAA receptor chloride channels.
 Infusion of picrotoxin has stimulant and convulsant
effects.
 Used to counter barbiturate poisoning, that can occur
during general anesthesia or during a large intake
outside of the hospital.
II. Hallucinogens (psychotomimetic)
 A few drugs have the ability to induce altered
perceptual states reminiscent of dreams, are
accompanied by bright, colourful changes in the
environment and by a plasticity of constantly
changing shapes and colour.
 The individual under the influence of these drugs is
incapable of normal decision making, because the
drug interferes with rational thought.
29
A. Lysergic acid diethylamide (LSD)
 Multiple sites in the CNS are affected by (LSD) and
shows serotonin (5-HT) agonist.
 It produces hallucinations with a dreamlike state (LSD
trip).
 Activation of the sympathetic nervous system occurs,
which causes pupillary dilation, increased BP,
piloerection, and increased body temperature.
 Uses: treatment of alcoholism, pain and cluster
headache relief, end-of-life anxiety, for spiritual
purposes, and to enhance creativity.
30
Adverse effects:
 Include hyperreflexia, nausea, and muscular weakness.
 High doses may produce long-lasting psychotic
changes in susceptible individuals.
 Temporarily impair the ability to make sensible
judgments and understand common dangers,
temporary confusion, difficulty with abstract thinking, or
signs of impaired memory and attention span, thus
making the user more susceptible to accidents and
personal injury.
31
B. Tetrahydrocannabinol (THC)
 The main psychoactive alkaloid contained in marijuana is
tetrahydrocannabinol (THC), which is available as
dronabinol.
 THC can produce euphoria, followed by drowsiness and
relaxation.
 Affect short-term memory and mental activity, decreases
muscle strength and impairs highly skilled motor activity,
such as that required to drive a car.
 SE: appetite stimulation, xerostomia, visual hallucinations,
delusions, and enhancement of sensory activity.
32
Mechanism of action:
 THC receptors, designated CB1 receptors, have been
found on inhibitory presynaptic nerve terminals.
CB1 is coupled to a G protein.
 Interestingly, endocannabinoids have been identified in
the CNS.
 These compounds, which bind to the CB1 receptors, are
membrane-derived and are synthesized on demand, and
they may act as local neuromodulators.
 The action of THC is believed to be mediated through the
CB1 receptors but is still under investigation.
33
Pharmacokinetics:
 The effects of THC appear immediately after the drug is
smoked, but maximum effects take about 20 minutes.
By 3 hours, the effects largely disappear.
 Dronabinol is administered orally and has a peak effect in
2 to 4 hours. Its psychoactive effects can last up to 6 hours,
but its appetite-stimulant effects may persist for 24 hours.
 It is highly lipid soluble and has a large volume of
distribution.
 THC itself is extensively metabolized by the mixed-function
oxidases.
 Elimination: is largely through the biliary route.
34
Therapeutic uses of Dronabinol
 As an appetite stimulant for patients with acquired
immunodeficiency syndrome who are losing weight.
 It is also sometimes given for the severe emesis caused
by some cancer chemotherapeutic agents.
Adverse effects:
Include increased heart rate, decreased blood pressure,
and reddening of the conjunctiva.
 At high doses, a toxic psychosis develops. Tolerance and
mild physical dependence occur with continued, frequent
use of the drug.
35
C. Rimonabant:
Cannabinoid receptor 1 (CB1) antagonist
 is an anorectic antiobesity drug that use to treat
obesity (decrease appetite and body weight in
humans).
 induces psychiatric disturbances, such as anxiety
and depression, during clinical trials.
36
D. Phencyclidine:
 Phencyclidine (also known as PCP, or “angel dust”).
 inhibits the reuptake of dopamine, 5-HT, and NE.
 The major action of phencyclidine is to block the ion
channel regulated by the NMDA subtype of glutamate
receptor.
 recreational dissociative drug produces analgesia and
anesthesia, can be ingested, smoked, inhaled or injected.
 Phencyclidine causes anticholinergic activity with severe
changes in body image, loss of ego boundaries, paranoia,
depersonalization. Hallucinations, euphoria, and suicidal
impulses also reported.
37
38
Q: A very agitated young male was brought to the
emergency room by the police. Psychiatric
examination revealed that he had snorted
cocaine several times in the past few days, the
last time being 10 hours previously. He was given
a drug which seated him and fell asleep. The
drug very likely used to counter this patient’s
apparent cocaine withdrawal was:
A: Phenobarbital B: Lorazepam
C: Cocaine D: Salbutamol
E: Adrenaline

Contenu connexe

Similaire à CNS-stimulants.pdf

Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
raj kumar
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
raj kumar
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
raj kumar
 
Disorders of the reward system
Disorders of the reward systemDisorders of the reward system
Disorders of the reward system
Adonis Sfera, MD
 
CNS STIMULANTS & COGNITIVE ENHANCERS
CNS STIMULANTS&COGNITIVE ENHANCERSCNS STIMULANTS&COGNITIVE ENHANCERS
CNS STIMULANTS & COGNITIVE ENHANCERS
GHSPL
 
Cns stimulants by Dr. Nadeem Korai
Cns stimulants by Dr. Nadeem KoraiCns stimulants by Dr. Nadeem Korai
Cns stimulants by Dr. Nadeem Korai
Nadeemkorai
 

Similaire à CNS-stimulants.pdf (20)

2-CNS-stimulant.ppt
2-CNS-stimulant.ppt2-CNS-stimulant.ppt
2-CNS-stimulant.ppt
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Tobacco Addiction
Tobacco AddictionTobacco Addiction
Tobacco Addiction
 
Stimulants
StimulantsStimulants
Stimulants
 
6 Pharmacology I CNS Stimulants NK, trimmed.pptx
6 Pharmacology I CNS Stimulants NK, trimmed.pptx6 Pharmacology I CNS Stimulants NK, trimmed.pptx
6 Pharmacology I CNS Stimulants NK, trimmed.pptx
 
Disorders of the reward system
Disorders of the reward systemDisorders of the reward system
Disorders of the reward system
 
substance dependance.pptx
substance dependance.pptxsubstance dependance.pptx
substance dependance.pptx
 
cnsstimulants & cognitive enhancers.pptx
cnsstimulants & cognitive enhancers.pptxcnsstimulants & cognitive enhancers.pptx
cnsstimulants & cognitive enhancers.pptx
 
Drugs Of Abuse
Drugs Of AbuseDrugs Of Abuse
Drugs Of Abuse
 
CNS stimulants
CNS stimulantsCNS stimulants
CNS stimulants
 
CNS STIMULANTS & COGNITIVE ENHANCERS
CNS STIMULANTS&COGNITIVE ENHANCERSCNS STIMULANTS&COGNITIVE ENHANCERS
CNS STIMULANTS & COGNITIVE ENHANCERS
 
CNS stimulants & cognitive enhancers
CNS stimulants & cognitive enhancersCNS stimulants & cognitive enhancers
CNS stimulants & cognitive enhancers
 
Psychiatric drugs of abuse
Psychiatric drugs of abusePsychiatric drugs of abuse
Psychiatric drugs of abuse
 
CNS stimulants and cognitive enhancers
CNS stimulants and cognitive enhancersCNS stimulants and cognitive enhancers
CNS stimulants and cognitive enhancers
 
stimulants
stimulantsstimulants
stimulants
 
Central Nervous System Stimulants presentation
Central Nervous System Stimulants presentationCentral Nervous System Stimulants presentation
Central Nervous System Stimulants presentation
 
Cns stimulants by Dr. Nadeem Korai
Cns stimulants by Dr. Nadeem KoraiCns stimulants by Dr. Nadeem Korai
Cns stimulants by Dr. Nadeem Korai
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 

Plus de Imtiyaz60

Asthma and COPD PATHOPHYSIOLOGY .pptx
Asthma and COPD PATHOPHYSIOLOGY    .pptxAsthma and COPD PATHOPHYSIOLOGY    .pptx
Asthma and COPD PATHOPHYSIOLOGY .pptx
Imtiyaz60
 
Angina and MI PATHOPHYSIOLOGY .pdf
Angina and MI PATHOPHYSIOLOGY       .pdfAngina and MI PATHOPHYSIOLOGY       .pdf
Angina and MI PATHOPHYSIOLOGY .pdf
Imtiyaz60
 
ATHEROSCLEROSIS pathophysiology .pptx
ATHEROSCLEROSIS pathophysiology    .pptxATHEROSCLEROSIS pathophysiology    .pptx
ATHEROSCLEROSIS pathophysiology .pptx
Imtiyaz60
 
PATHOLOGY OF HYPERTENSION .ppt
PATHOLOGY OF HYPERTENSION           .pptPATHOLOGY OF HYPERTENSION           .ppt
PATHOLOGY OF HYPERTENSION .ppt
Imtiyaz60
 
Hypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptxHypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptx
Imtiyaz60
 
Appetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptxAppetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptx
Imtiyaz60
 
Anti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classificationAnti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classification
Imtiyaz60
 
gingerasafoetida.pptx
gingerasafoetida.pptxgingerasafoetida.pptx
gingerasafoetida.pptx
Imtiyaz60
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptx
Imtiyaz60
 
strokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptxstrokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptx
Imtiyaz60
 
Thyroid gland.pptx
Thyroid gland.pptxThyroid gland.pptx
Thyroid gland.pptx
Imtiyaz60
 
inflammatory bowel diseas.pptx
inflammatory bowel diseas.pptxinflammatory bowel diseas.pptx
inflammatory bowel diseas.pptx
Imtiyaz60
 
tannins-170116185017.pptx
tannins-170116185017.pptxtannins-170116185017.pptx
tannins-170116185017.pptx
Imtiyaz60
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
Imtiyaz60
 
tuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptxtuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptx
Imtiyaz60
 
2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt
Imtiyaz60
 
Electrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptxElectrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptx
Imtiyaz60
 
rheumatoidarthritispptbyann-160402080357.pptx
rheumatoidarthritispptbyann-160402080357.pptxrheumatoidarthritispptbyann-160402080357.pptx
rheumatoidarthritispptbyann-160402080357.pptx
Imtiyaz60
 

Plus de Imtiyaz60 (20)

asthma .pptx
asthma                                             .pptxasthma                                             .pptx
asthma .pptx
 
Asthma and COPD PATHOPHYSIOLOGY .pptx
Asthma and COPD PATHOPHYSIOLOGY    .pptxAsthma and COPD PATHOPHYSIOLOGY    .pptx
Asthma and COPD PATHOPHYSIOLOGY .pptx
 
Angina and MI PATHOPHYSIOLOGY .pdf
Angina and MI PATHOPHYSIOLOGY       .pdfAngina and MI PATHOPHYSIOLOGY       .pdf
Angina and MI PATHOPHYSIOLOGY .pdf
 
ATHEROSCLEROSIS pathophysiology .pptx
ATHEROSCLEROSIS pathophysiology    .pptxATHEROSCLEROSIS pathophysiology    .pptx
ATHEROSCLEROSIS pathophysiology .pptx
 
PATHOLOGY OF HYPERTENSION .ppt
PATHOLOGY OF HYPERTENSION           .pptPATHOLOGY OF HYPERTENSION           .ppt
PATHOLOGY OF HYPERTENSION .ppt
 
Hypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptxHypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptx
 
Appetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptxAppetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptx
 
Anti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classificationAnti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classification
 
gingerasafoetida.pptx
gingerasafoetida.pptxgingerasafoetida.pptx
gingerasafoetida.pptx
 
leprosy.pptx
leprosy.pptxleprosy.pptx
leprosy.pptx
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptx
 
strokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptxstrokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptx
 
Thyroid gland.pptx
Thyroid gland.pptxThyroid gland.pptx
Thyroid gland.pptx
 
inflammatory bowel diseas.pptx
inflammatory bowel diseas.pptxinflammatory bowel diseas.pptx
inflammatory bowel diseas.pptx
 
tannins-170116185017.pptx
tannins-170116185017.pptxtannins-170116185017.pptx
tannins-170116185017.pptx
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
 
tuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptxtuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptx
 
2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt
 
Electrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptxElectrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptx
 
rheumatoidarthritispptbyann-160402080357.pptx
rheumatoidarthritispptbyann-160402080357.pptxrheumatoidarthritispptbyann-160402080357.pptx
rheumatoidarthritispptbyann-160402080357.pptx
 

Dernier

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
ssuserdda66b
 

Dernier (20)

SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 

CNS-stimulants.pdf

  • 1. CNS STIMULANTS 1 Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D.
  • 2. 1. Psychomotor stimulants cause: Excitement, Euphoria, Decrease feeling of fatigue and Increase motor activity Ex. Methylxanthines (caffeine, theobromine, theophylline), nicotine, cocaine, amphetamine, atomoxetine, modafinil, methylphenidate. 2. Hallucinogens (psychotomimetic) Affect thought, perception, and mood Ex. Lysergic acid diethylamide (LSD), Phencyclidine (PCP), Tetrahydrocannabinol (THC), Rimonabant. 2 CNS stimulants
  • 3. Therapeutic Indications and Contraindications for CNS Stimulants Obesity (anorectic agents). Attention Deficit Hyperactivity Disorder (ADHD); lack the ability to be involved in any one activity for longer than a few minutes. Narcolepsy: It is a relatively rare sleep disorder, that is characterized by uncontrollable bouts of sleepiness during the day. It is sometimes accompanied by catalepsy, a loss in muscle control, or even paralysis brought on by strong emotion, such as laughter. Contraindications: patients with anorexia, insomnia, asthenia, psychopathic personality, a history of homicidal or suicidal tendencies. 3
  • 4. 1. Psychomotor stimulants A. Methylxanthines 1. Theophylline (found in tea): long-acting, prescribed for night-time asthma 2. Theobromine: found in cocoa. 3. Caffeine: (short-acting) the most widely consumed  found in coffee (200 mg/cup),  carbonated soft drinks (60 mg/can),  cocoa and chocolate 4
  • 5. Mechanism of action: include several mechanism have been proposed Mechanism of action of methylxanthine 1-It inhibits phosphodiesterase enz. → ↑ cAMP 2- Adenosine (A1, A2 and A3) receptors antagonist almost equally, which explains many of its cardiac effects A2 receptors antagonist responsible for CNS stimulation & smooth muscles relaxation ↓calcium in Smooth muscles ↑ calcium in CNS & heart 5
  • 6. Actions a. CNS:  decrease in fatigue, increased alertness: 100-200 mg caffeine in 1 or 2 cups of coffees  Anxiety & tremors- 1.5 g of caffeine: 12-15 cups of coffee  Spinal cord stimulation: 2-5 g (very high dose) Tolerance can rapidly develop Withdrawal symptoms: feeling of fatigue & sedation. b. CVS: at high dose of caffeine +ve inotropic and chronotropic effects on the heart, ↑COP c. Diuretic action: mild ↑ urinary output of Na+, Cl- and K+ d. Gastric mucosa: all methylxanthines stimulate secretion of HCl e. Respiratory smooth muscle: bronchodilator, Rx asthma replaced by β-agonists, corticosteroids. 6
  • 7. Pharmacokinetics  The methylxanthines are well absorbed orally.  Caffeine distributes throughout the body, including the brain. The drugs cross the placenta to the fetus and is secreted into the mother's milk.  All are metabolized in the liver, generally by the CYP1A2 pathway, the metabolites are then excreted in the urine. Adverse effects  Moderate doses: insomnia, anxiety, agitation  High doses: emesis, convulsion  Lethal dose (10 gm of caffeine): cardiac arrhythmia  Suddenly stop: lethargy, irritability, headache 7
  • 8. B. Nicotine:  Nicotine is the active ingredient in tobacco.  Used in smoking cessation therapy,  Nicotine remains important, because:  it is 2nd only to caffeine as the most widely used CNS stimulant  and 2nd only to alcohol as the most abused drug. Actions of Nicotine: Low dose: ganglionic depolarization High dose: ganglionic blockade 8
  • 9. Actions of Nicotine I. CNS: 1. Low dose: euphoria, arousal, relaxation, improves attention, learning, problem solving and reaction time. 2. High dose: CNS paralysis, severe hypotension (medullary paralysis) II. Peripheral effects:  Stimulation of sympathetic ganglia and adrenal medulla→↑ BP and HR (harmful in HTN patients)  Stimulation of parasympathetic ganglia→↑ motor activity of the bowel  At higher doses, BP falls & activating ceases in both GIT and bladder 9
  • 10. Pharmacokinetics:  highly lipid soluble absorbed everywhere (oral mucosa, lung, GIT, skin).  Crosses the placental membrane, secreted with milk.  Most cigarettes contain 6-8 mg of nicotine, by inhaling tobacco smoke, the average smoker takes in 1 to 2 mg of nicotine per cigarette.  the acute lethal dose is 60 mg,  90% of nicotine inhaled in smoke is absorbed.  Tolerance to toxic effects of nicotine develops rapidly. 10
  • 11. Adverse effects:  CNS; irritability and tremors  Intestinal cramps, diarrhea  ↑HR & BP Withdrawal syndrome: nicotine is addictive substance  physical dependence on nicotine develops rapidly and can be severe.  Bupropion: can reduce the craving for cigarettes  Transdermal patch and chewing gum containing nicotine 11
  • 12. C. Varenicline  Partial agonist at Nicotinic receptor in CNS.  It produces less euphoric effects than those produced by nicotine itself (nicotine is full agonist at these receptors).  Thus, it is useful as an adjunct in the management of smoking cessation in patients with nicotine withdrawal symptom.  SE: Nausea, change in taste, vomiting, abdominal pain, flatulence, and constipation.  Serious side-effects, including suicidal behavior and depression 12
  • 13. D. Cocaine (highly addictive drug) Mechanism of action: blockade of reuptake of the monoamines (NE, serotonin and dopamine). Thus, potentiates and prolongs the CNS and peripheral actions of these monoamines. Only clinical use as local anesthetics. 13
  • 14. Action:  Initially produces the intense euphoria by prolongation of dopaminergic effects in the brain’s pleasure system (limbic system) producing the “Rush”.  This follows by dysphoria in few minutes as it is degraded by plasma estrases 14  Chronic intake of cocaine depletes dopamine. This depletion triggers the vicious cycle of craving for cocaine.
  • 15. Pharmacological effects: a. CNS-behavioral effects result from powerful stimulation of cortex and brain stem.  Cocaine acutely increases mental awareness and produces a feeling of wellbeing and euphoria similar to that produced by amphetamine.  Like amphetamine, cocaine can produce hallucinations and delusions of paranoia or grandiosity.  Cocaine increases motor activity, and at high doses, it causes tremors and convulsions, followed by respiratory and vasomotor depression. 15
  • 16. b. Sympathetic NS: peripherally potentiate the action of NE→ fight or flight c. Hyperthermia:  impair sweating & cutaneous vasodilation  ↓Perception of thermal discomfort d. local anesthetic action: blockade of voltage- activated Na+ channel.  Cocaine is the only LA that causes vasoconstriction, chronic inhalation of cocaine powder → necrosis and perforation of the nasal septum  Cocaine is often self-administered by chewing, intranasal snorting, smoking, or intravenous (IV) injection. Pharmacological effects : 16
  • 17. Adverse effects:  Anxiety reaction that includes: hypertension, tachycardia, sweating, and paranoia. Because of the irritability, many users take cocaine with alcohol. A product of cocaine metabolites and ethanol is cocaethylene, which is also psychoactive and cause cardiotoxicity.  Depression: Like all stimulant drugs, cocaine stimulation of the CNS is followed by a period of mental depression.  Addicts withdrawing from cocaine exhibit physical and emotional depression as well as agitation. The latter symptom can be treated with benzodiazepines or phenothiazines.  Toxic effects:  Seizures treated by I.V diazepam  Fatal cardiac arrhythmias treated by propranolol 17
  • 18. E. Amphetamine  Is a non catecholamine, (shows neurologic and clinical effects quite similar to those of cocaine).  dextroamphetamine is the major member of this class compounds.  methamphetamine (speed) is a derivative of amphetamine that can be smoked and it is preferred by many abusers.  Methylenedioxymethamphetamine (also known as MDMA, or Ecstasy) is a synthetic derivative of methamphetamine with both stimulant and hallucinogenic properties. 18
  • 19. Mechanism of action: Amphetamine, act by  releasing intracellular stores of catecholamines.  also inhibits MAO, high level catecholamines are readily released into synaptic spaces. 19
  • 20. Actions: a. CNS: the major behavioral effects of amphetamine result from a combination of its dopamine and NE release enhancing properties.  Amphetamine stimulates the entire cerebrospinal axis, brainstem, and medulla.  This leads to increase alertness, decrease fatigue, depressed appetite, and insomnia. b. Sympathetic Nervous System: indirectly stimulating the receptors through NE release. 20
  • 21. Adverse effects: The amphetamines may cause addiction, dependence, tolerance, and drug seeking behavior. a. CNS: insomnia, irritability, weakness, dizziness, tremor, hyperactive reflex, confusion, delirium, panic states, and suicidal tendencies, especially in mentally ill patients. -Chronic amphetamine use produces a state of “amphetamine psychosis” that resembles the psychotic episodes associated with schizophrenia. -Whereas long-term amphetamine is associated with psychic and physical dependence, tolerance to its effects may occur within few weeks. 21
  • 22. Adverse effects: The anorectic effect of amphetamine is due to its action in the lateral hypothalamic feeding center. b. CVS: palpitations, cardiac arrhythmia, HTN, anginal pain, and circulatory collapse. Headache, chills, and excess sweating may also occur. c. GIT: anorexia, nausea, vomiting, abdominal cramps, and diarrhea. Overdoses are treated with chlorpromazine or haloperidol, with urine acidification to enhance excretion. Contraindications: HTN, CV diseases, glaucoma, hyperthyroidism, patients with a history of drug abuse 22
  • 23. F. Atomoxetine  It is a NE reuptake inhibitor (should not be taken by individual on MAO inhibitors).  Approved for ADHD (significant problems of attention, hyperactivity, or acting impulsively) in children and adults.  SE: Nausea, Xerostomia (dry mouth), appetite loss, Insomnia, Irritability, hypertension and Hostility.  It is not habit forming and is not a controlled substance. 23
  • 24. G. Methylphenidate  It has CNS stimulant properties similar to those of amphetamine and may also lead to abuse.  Methylphenidate is a more potent dopamine transport inhibitor than cocaine, thus making more dopamine available.  It has less potential for abuse than cocaine, because it enters the brain much more slowly than cocaine and, does not increase dopamine levels as rapidly. 24
  • 25. Therapeutic uses:  Methylphenidate and its active isomer, (Dexmethylphenidate), have been used for several decades in the treatment of ADHD in children aged 6 to 16.  It is also effective in the treatment of narcolepsy. 25
  • 26. Adverse reactions:  GIT effects are the most common; abdominal pain and nausea.  Other reactions include anorexia, insomnia, nervousness, and fever.  In seizure patients, methylphenidate seems to increase the seizure frequency, especially if the patient is taking antidepressants.  Methylphenidate is contraindicated in patients with glaucoma. 26
  • 27. Narcolepsy: (day time sleepiness)  Amphetamine, methylphenidate.  Recently, a new drug, modafinil (wakefulness- promoting agent) and its R-enantiomer derivative, armodafinil, have become available to treat narcolepsy.  Modafinil produces fewer psychoactive and euphoric effects as well as, alterations in mood, perception, thinking, and feelings typical of other CNS stimulants. 27
  • 28. 28 H. Picrotoxin (cocculin)  Is a poisonous crystalline plant compound.  It acts as a non-competitive channel blocker for the GABAA receptor chloride channels.  Infusion of picrotoxin has stimulant and convulsant effects.  Used to counter barbiturate poisoning, that can occur during general anesthesia or during a large intake outside of the hospital.
  • 29. II. Hallucinogens (psychotomimetic)  A few drugs have the ability to induce altered perceptual states reminiscent of dreams, are accompanied by bright, colourful changes in the environment and by a plasticity of constantly changing shapes and colour.  The individual under the influence of these drugs is incapable of normal decision making, because the drug interferes with rational thought. 29
  • 30. A. Lysergic acid diethylamide (LSD)  Multiple sites in the CNS are affected by (LSD) and shows serotonin (5-HT) agonist.  It produces hallucinations with a dreamlike state (LSD trip).  Activation of the sympathetic nervous system occurs, which causes pupillary dilation, increased BP, piloerection, and increased body temperature.  Uses: treatment of alcoholism, pain and cluster headache relief, end-of-life anxiety, for spiritual purposes, and to enhance creativity. 30
  • 31. Adverse effects:  Include hyperreflexia, nausea, and muscular weakness.  High doses may produce long-lasting psychotic changes in susceptible individuals.  Temporarily impair the ability to make sensible judgments and understand common dangers, temporary confusion, difficulty with abstract thinking, or signs of impaired memory and attention span, thus making the user more susceptible to accidents and personal injury. 31
  • 32. B. Tetrahydrocannabinol (THC)  The main psychoactive alkaloid contained in marijuana is tetrahydrocannabinol (THC), which is available as dronabinol.  THC can produce euphoria, followed by drowsiness and relaxation.  Affect short-term memory and mental activity, decreases muscle strength and impairs highly skilled motor activity, such as that required to drive a car.  SE: appetite stimulation, xerostomia, visual hallucinations, delusions, and enhancement of sensory activity. 32
  • 33. Mechanism of action:  THC receptors, designated CB1 receptors, have been found on inhibitory presynaptic nerve terminals. CB1 is coupled to a G protein.  Interestingly, endocannabinoids have been identified in the CNS.  These compounds, which bind to the CB1 receptors, are membrane-derived and are synthesized on demand, and they may act as local neuromodulators.  The action of THC is believed to be mediated through the CB1 receptors but is still under investigation. 33
  • 34. Pharmacokinetics:  The effects of THC appear immediately after the drug is smoked, but maximum effects take about 20 minutes. By 3 hours, the effects largely disappear.  Dronabinol is administered orally and has a peak effect in 2 to 4 hours. Its psychoactive effects can last up to 6 hours, but its appetite-stimulant effects may persist for 24 hours.  It is highly lipid soluble and has a large volume of distribution.  THC itself is extensively metabolized by the mixed-function oxidases.  Elimination: is largely through the biliary route. 34
  • 35. Therapeutic uses of Dronabinol  As an appetite stimulant for patients with acquired immunodeficiency syndrome who are losing weight.  It is also sometimes given for the severe emesis caused by some cancer chemotherapeutic agents. Adverse effects: Include increased heart rate, decreased blood pressure, and reddening of the conjunctiva.  At high doses, a toxic psychosis develops. Tolerance and mild physical dependence occur with continued, frequent use of the drug. 35
  • 36. C. Rimonabant: Cannabinoid receptor 1 (CB1) antagonist  is an anorectic antiobesity drug that use to treat obesity (decrease appetite and body weight in humans).  induces psychiatric disturbances, such as anxiety and depression, during clinical trials. 36
  • 37. D. Phencyclidine:  Phencyclidine (also known as PCP, or “angel dust”).  inhibits the reuptake of dopamine, 5-HT, and NE.  The major action of phencyclidine is to block the ion channel regulated by the NMDA subtype of glutamate receptor.  recreational dissociative drug produces analgesia and anesthesia, can be ingested, smoked, inhaled or injected.  Phencyclidine causes anticholinergic activity with severe changes in body image, loss of ego boundaries, paranoia, depersonalization. Hallucinations, euphoria, and suicidal impulses also reported. 37
  • 38. 38 Q: A very agitated young male was brought to the emergency room by the police. Psychiatric examination revealed that he had snorted cocaine several times in the past few days, the last time being 10 hours previously. He was given a drug which seated him and fell asleep. The drug very likely used to counter this patient’s apparent cocaine withdrawal was: A: Phenobarbital B: Lorazepam C: Cocaine D: Salbutamol E: Adrenaline